Leading pharmaceutical companies join Vivli’s new global register to accelerate research into antibiotic resistant bacteria CAMBRIDGE, Mass., June 21, 2022 /PRNewswire/ — The Antimicrobial Resistance Register, unveiled today by the nonprofit organization Vivli, makes it […]
Industry veteran brings proven track record in building successful businesses and leading high-performance teams across large pharmaceutical, biotech, and specialty pharma companies CAMBRIDGE, Mass., June 21, 2022 /PRNewswire/ — QurAlis Corporation, a biotech company developing… […]
WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today presented Tolerizing Antigen Carrier (TACs) nonclinical results at the 2022 Federation of Clinical Immunology […]
The survey results provided “valuable and worrying insights about the state of oral health in the U.S,” according to CareQuest Institute of Oral Health. Click here to view original post
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Click here to view original post
June 16, 2022 – Both the Moderna and Pfizer vaccines for COVID-19 are very safe and strongly recommended, according to a new study. Researchers from the VA Boston Healthcare System, the CAUSALab at Harvard T.H. […]
This week, Amylyx scored its first-ever regulatory approval from Health Canada for its ALS drug. Click here to view original post
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that it is collaborating with Novartis, a leading global medicines company, to expand newborn screening for sickle cell disease […]
Fallon Health has named its chief medical officer — and it didn’t have to look very far to find its choice. Click here to view original post
CAMBRIDGE, Mass., June 15, 2022 /PRNewswire/ — Marengo Therapeutics, Inc., a company pioneering novel therapeutics that directly target the Vβ chain of the T cell receptor (TCR) to activate the right T cell subsets to […]
© 2022 Biotech Networks, LLC
